United States · Series A startup

Who invested in Silverback Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$38Mraised across 1 round since 2018, from 1 source

Latest round
Series A, $38MSept 2018
Investors
2
See who backed them

The rounds

  1. Sept 2018
    Series A$38M

    Reported by GeekWireSEC filing: $12M sold, first sale Sept 2018

Founders and team

From Silverback Therapeutics's own website and the SEC filings it signed: 8 on the team.

  • Daniel RelovskySenior Vice President, Marketing
  • Donn CasalePresident, CEO, and Director
  • Justin ChakmaChief Business Officer
  • Kathleen ScottChief Financial Officer
  • Meg SmithChief Commercial Officer
  • Corporate GovernanceBoard of Directors
  • Stock InformationAnalyst Coverage
  • Laura ShawverExecutive Officer, Directori

On the board, as filediJonathan L. RootPeter A. ThompsonRobert L. HershbergSaqib L. IslamScott L. PlatshonThilo L. SchroederVickie L. Capps

Everyone who backed them

OrbiMed/ Celegeneno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Silverback Therapeutics

Who invested in Silverback Therapeutics?

Silverback Therapeutics's investors include Alexandria Real Estate Equities and OrbiMed/ Celegene.

How much has Silverback Therapeutics raised?

Silverback Therapeutics has raised $38M across 1 round since 2018.

When did Silverback Therapeutics last raise?

Silverback Therapeutics's most recent round was a Series A of $38M in Sept 2018.

What was Silverback Therapeutics's biggest round?

Its most recent round, $38M in Sept 2018, is also its largest on record.

Who backed Silverback Therapeutics first?

Silverback Therapeutics's first round on record, in Sept 2018, was backed by Alexandria Real Estate Equities and OrbiMed/ Celegene.

What stage is Silverback Therapeutics at?

Silverback Therapeutics's latest named round is a Series A, in Sept 2018.

Where is Silverback Therapeutics based?

Silverback Therapeutics is based in the United States.

Companies like Silverback Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.